March 2025 Life Sciences Update

CONTENTS

The European life sciences market enters 2025 with greater confidence. Macro conditions may remain uncertain, but an improvement in debt markets and VC flows to life sciences should support further improvement in corporate activity and greater occupier confidence. With more investment in late stage business models and the integration of AI to help optimize R&D strategies and lab design, momentum in the market is set to pick up.

Cushman & Wakefield

46